Science is hard...optimistic that we can find new business models to facilitate great science. Husband, father, step-father, runner, Michigan football fan
Last call for #Science2Startup submissions! Submit a one-page overview of your idea at https://t.co/X2tL1RJSuZ by Monday, December 5!
Selected presenters will receive mentorship from a team curated by @MassBio and S2S Advisors!
Last chance to reserve your seat for the final part of our ‘Spotlight on Aging’ webinar series. Join Leesa Gentry, SVP Global Clinical Development, for the final session tomorrow, Wednesday 16th November @ 5pm CET / 4pm GMT / 11am EST | https://t.co/Mnwn3efjry
Evotec SE and @TIAPToronto today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include @Amgen as a strategic partner. Read the full press release here - https://t.co/gStuytXToo #researchneverstops
Evotec is the winner of a 2022 CMO Leadership Award in the Expertise and Service categories of Life Science Leader-Outsourced Pharma’s award program! Learn more about the awards here - https://t.co/mpNQb1Nb8V #researchneverstops
Evotec SE announced today that the Company has entered a target and drug discovery partnership with @Boehringer, focusing on induced pluripotent stem cell (“iPSC”)-based disease modelling for ophthalmologic disorders - https://t.co/waruhKfxIh #researchneverstops
Evotec SE announced today that the Company has entered into both a licensing and master service agreement with @KaziaTx, an Australian #oncology -focused biotechnology company | Press release https://t.co/eumvdezHOf | [email protected]#researchneverstops
Easy and inspiring read: the beauty of process improvement in #drugdiscovery. Helps me understand why staff turnover at @Evotec is so low. Makes work sound like fun. Via @Labiotech_eu $EVT.F